Indaptus Therapeutics, Inc. (INDP)
NASDAQ: INDP · Real-Time Price · USD
2.080
+0.230 (12.43%)
At close: Sep 9, 2026, 4:00 PM EDT
2.000
-0.080 (-3.85%)
Pre-market: Sep 10, 2026, 9:17 AM EDT
Indaptus Therapeutics Market Cap
Indaptus Therapeutics has a market cap or net worth of $277.14 million as of September 9, 2026. Its market cap has increased by 8,506.96% in one year.
Market Cap
277.14M
Enterprise Value
265.59M
1-Year Change
8,506.96%
Ranking
Category
Stock Price
$2.08
ChartMarket Cap Chart
Since August 4, 2021, Indaptus Therapeutics's market cap has increased from $47.95M to $277.14M, an increase of 477.98%. That is a compound annual growth rate of 41.04%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2026 | 277.14M | 5,338.59% |
| Dec 31, 2025 | 5.10M | -49.63% |
| Dec 31, 2024 | 10.12M | -31.58% |
| Dec 29, 2023 | 14.79M | 21.38% |
| Dec 30, 2022 | 12.18M | -73.92% |
| Dec 31, 2021 | 46.70M | -2.60% |
| Aug 4, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Fulcrum Therapeutics | 292.98M |
| Fate Therapeutics | 292.36M |
| Pyxis Oncology | 281.92M |
| ProQR Therapeutics | 280.83M |
| Bicycle Therapeutics | 280.32M |
| Foghorn Therapeutics | 277.33M |
| YD Bio | 276.01M |
| AC Immune | 274.42M |